Results 141 to 150 of about 357,486 (216)

Primary Immunodeficiency Diseases in COVID-19 Pandemic: A Predisposing or Protective Factor? [PDF]

Am J Med Sci, 2020
Babaha F, Rezaei N.
europepmc   +1 more source

(3) Clinicopathological Features and Etiopathogeneses of Defective Defense Mechanisms in Primary Immunodeficiency Diseases

, 1983
T Kanoh, Norimasa Yasuda
openalex   +2 more sources

Specialist Physician Perspectives On Primary Immunodeficiency Diseases: A 2006 Survey Of The AAAAI Membership [PDF]

, 2007
Jordan S. Orange, J. Boyle
openalex   +1 more source

Efficacy, Safety, Tolerability, and Serum IgG Trough Levels of Hyaluronidase-Facilitated Subcutaneous Immunoglobulin 10% in US Pediatric Patients with Primary Immunodeficiency Diseases. [PDF]

J Clin Immunol
Patel NC, Walter JE, Wasserman RL, Rubinstein A, Kankirawatana S, Shepherd MW, Greco E, Li Z, Russo-Schwarzbaum S, Saeed-Khawaja S, McCoy B, Yel L.   +11 more
europepmc   +1 more source

Variable course of primary simian immunodeficiency virus infection in lymph nodes: relation to disease progression [PDF]

, 1994
Lisa A. Chakrabarti, Marie‐Christine Cumont, Luc Montagnier, Bruno Hurtrel   +3 more
openalex   +1 more source

Association of Primary Humoral Immunodeficiencies With Psychiatric Disorders and Suicidal Behavior and the Role of Autoimmune Diseases [PDF]

, 2020
Josef Isung, Kyle A. Williams, Kayoko Isomura, Caroline Gromark, Eva Hesselmark, Paul Lichtenstein, Henrik Larsson, Lorena Fernández de la Cruz, Anna Sidorchuk, David Mataix‐Cols   +9 more
openalex   +1 more source

Screening for primary immunodeficiency diseases by next-generation sequencing in early life. [PDF]

Clin Transl Immunology, 2020
Sun J, Yang L, Lu Y, Wang H, Peng X, Dong X, Cheng G, Cao Y, Wu B, Wang X, Zhou W.   +10 more
europepmc   +1 more source

Rare Primary and Combined Immunodeficiency Disease: A Case Report from Paediatric Emergency Reception of Sher-i-Kashmir Institute of Medical Sciences, Soura, Srinagar, Jammu and Kashmir, India

Noorul Amin, Noorul Amin
openalex   +2 more sources

The replicative fitness of primary human immunodeficiency virus type 1 (HIV-1) group M, HIV-1 group O, and HIV-2 isolates [PDF]

, 2005
ABRAHA, A, Ariën, Kevin, ARTS, EJ, KESTENS, L, QUINONES-MATEU, ME, VANHAM, G   +5 more
core   +1 more source

Long-Term Safety of Facilitated Subcutaneous Immunoglobulin 10% Treatment in US Clinical Practice in Patients with Primary Immunodeficiency Diseases: Results from a Post-Authorization Safety Study. [PDF]

J Clin Immunol
Rubinstein A, Mabudian M, McNeil D, Patel NC, Wasserman RL, Gupta S, Carrasco P, Chen J, Garcia E, Nagy A, Yel L.   +10 more
europepmc   +1 more source